Are you looking to file an Elmiron Eye Damage for your vision loss issues?

If you or someone you love has suffered from a side effect, an Elmiron lawyer may be able to help. Patients who have been harmed by prescription drugs can bring a lawsuit to seek compensation.

Numerous studies have shown that Elmiron long-term use, which is prescribed for interstitial cystitis treatment, can cause maculopathy, an eye disorder that can lead blindness.

Elmiron patients are suing Janssen Pharmaceuticals over these horrible side effects.

Elmiron Eye Damage is suing the drug manufacturer to recover damages for failing to warn of the serious side effects of the drug.

Vision loss is a major side effect. This eye damage can worsen over time, sometimes before symptoms appear.

Buckfire Law represents people who have taken Elmiron and sustained vision damage. This includes permanent vision loss, pigmentary maculopathy, and eye disease.

Free confidential case reviews by our top-rated lawyers are available. We never charge fees unless we provide you with a settlement check.

Your potential claim may be subject to different deadlines or statutes of limitations.

Our law firm will review your case for free.

Call one of our Elmiron litigation vision loss lawyers right away.

Elmiron: What is it?

What’s maculopathy?

Maculopathy symptoms

Elmiron related to vision loss

Vision Loss Lawsuit Criteria

What is ELMIRON?

Pentosan is also known as Elmiron. It is sodium pentosan sulfate sodium (PPS). This medication is used to treat interstitial cystitis. Also known as bladder pain syndrome, or painful bladder syndrome, it’s prescribed for treating this condition. The drug is not available in a generic form. Janssen Pharmaceuticals makes it.

Many patients take Elmiron for many years or even decades.

Elmiron was approved by the U.S. Food and Drug Administration (FDA) in 1995. It is used to treat osteoarthritis in humans, dogs and horses. Elmiron was once used as an anticoagulant similar to warfarin but with a weaker impact. This popular medication is now a household name and has a sales volume of over $150 million annually.

Although it is on the market since 1995 there are no warnings on the label about any side effects or visual changes. Multiple studies published in 2018 show that the drug can cause irreversible vision problems. Elmiron lawsuits against prescription drug manufacturers demand damages compensation.


According to the Center for Disease Control, more than 3.4million Americans aged 40 and older have vision issues. This includes those who are legally blind, or visually impaired.

Over the next 30 years, it is predicted that Americans will experience double the amount of vision loss. Blindness is most commonly caused by conditions such as advanced age-related macular disease, pigmentary maculopathy and glaucoma. As the population ages, these numbers will rise dramatically.

According to a report from the 2017 National Health Interview Survey,, approximately 19.1 million Americans aged 18-64 and 7.8 millions American adults 65 and older reported significant vision loss.

Below is a pie chart showing the percentage breakdown of American adults aged 18-64 and 65 years old who reported some or permanent vision impairment.


Medical studies have shown that Elmiron long-term use is linked to maculopathy. This side effect can cause blindness and eye disorders. People who have suffered from visual side effects due to Elmiron are facing Elmiron lawsuits.


Maculopathy refers to a condition that affects macula. This is the central portion of the retina responsible in delivering precise, sensitive vision.

Retinal condition maculopathy is characterised by progressive loss of central vision that can be bilateral or unilateral. This greatly impairs vision functions.

The “pigmentary maculopathy with unknown etiology” is the form of macular damage that can be attributed to Elmiron.


Painless macular degeneration or maculopathy is possible. Because the healthy eye compensates for any vision problems, medication users may not notice them.

Symptoms of pigmentary macularopathy usually begin with:

Metamorphopsis is an image distortion in which objects appear smaller and/or deformed.